These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12190194)

  • 1. Re: Postmarking adverse events related to sotradecol (sodium tetradecyl sulfate-sclerosing agent).
    Bonnel RA
    Am J Gastroenterol; 2002 Aug; 97(8):2140; author reply 2140. PubMed ID: 12190194
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylactoid reaction after the use of sodium tetradecyl sulfate: a case report.
    Brzoza Z; Kasperska-Zajac A; Rogala E; Rogala B
    Angiology; 2007; 58(5):644-6. PubMed ID: 18024951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic reactions to Sotradecol.
    Fronek H; Fronek A; Saltzberg G
    J Dermatol Surg Oncol; 1989 Jun; 15(6):684. PubMed ID: 2723231
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe?
    Goldman MP
    Dermatol Surg; 2004 Dec; 30(12 Pt 1):1454-6; discussion 1456. PubMed ID: 15606731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting of adverse drug events: a key to postmarketing drug safety.
    Rheinstein PH
    Am Fam Physician; 1992 Sep; 46(3):873-4. PubMed ID: 1514478
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anaphylactic shock following an injection of trombovar].
    Boespflug O
    Phlebologie; 1974; 27(2):191-3. PubMed ID: 4154466
    [No Abstract]   [Full Text] [Related]  

  • 7. Scrutinizing sclerotherapy.
    Bowman WE
    N C Med J; 1996; 57(3):127-8. PubMed ID: 8935354
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 9. MedWatch targets reporting of serious adverse events.
    VanAmringe M
    Jt Comm Perspect; 1993; 13(4):15. PubMed ID: 10129237
    [No Abstract]   [Full Text] [Related]  

  • 10. Localized hypertrichosis after sclerotherapy.
    Oh TS; Kim Y; Song HJ
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1064-5. PubMed ID: 20590714
    [No Abstract]   [Full Text] [Related]  

  • 11. Sclerotherapy of telangiectases using sodium tetradecyl sulfate (Sotradecol).
    Hren C; Garcia C; Clark RE
    N C Med J; 1996; 57(1):42-6. PubMed ID: 8821717
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thromboembolism and synthetic estroprogestational hormones. Apropos of 2 cases].
    Boespflug O
    Phlebologie; 1975; 28(3-4):373-4. PubMed ID: 1230800
    [No Abstract]   [Full Text] [Related]  

  • 13. Xyrem (sodium oxybate) postmarketing adverse event reporting system.
    Wang YG
    Sleep Med; 2010 Jun; 11(6):595; author reply 595-6. PubMed ID: 20362501
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaphylactic Shock After Injection of Foamed Sodium Tetradecyl Sulfate.
    Chang YY; Lu PH; Yang CH
    Dermatol Surg; 2017 Jun; 43(6):887-888. PubMed ID: 28114206
    [No Abstract]   [Full Text] [Related]  

  • 15. The dangers of sclerotherapy in the treatment of ganglia.
    Mackie IG; Howard CB; Wilkins P
    J Hand Surg Br; 1984 Jun; 9(2):181-4. PubMed ID: 6747425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions and reporting.
    Witte R
    Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine adverse event reporting: the importance of follow-up.
    Varricchio F
    Expert Rev Vaccines; 2005 Aug; 4(4):445-8. PubMed ID: 16117700
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA guidance document on monitoring delayed adverse events a good first start.
    Williams DA
    Mol Ther; 2005 Dec; 12(6):991-2. PubMed ID: 16271514
    [No Abstract]   [Full Text] [Related]  

  • 19. MEDWatch: the new FDA medical products reporting program.
    Kessler DA
    Am J Hosp Pharm; 1993 Jun; 50(6):1151-2. PubMed ID: 8517452
    [No Abstract]   [Full Text] [Related]  

  • 20. Radial artery injury caused by a sclerosant injected into a palmar wrist ganglion.
    Jalul M; Humphrey AR
    J Hand Surg Eur Vol; 2009 Oct; 34(5):698-9. PubMed ID: 19959458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.